High-throughput structural biology of metabolic enzymes and its impact on human diseases.
The Structural Genomics Consortium (SGC) is a public-private partnership that aims to determine the three-dimensional structures of human proteins of medical relevance and place them into the public domain without restriction. To date, the Oxford Metabolic Enzyme Group at SGC has deposited the struc...
Main Authors: | Yue, W, Oppermann, U |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
High-throughput structural biology of metabolic enzymes and its impact on human diseases
by: Yue, W, et al.
Published: (2011) -
High-throughput structural biology of metabolic enzymes and its impact on human diseases.
by: Yue, W, et al.
Published: (2011) -
Structural genomics and high throughput structural biology /
by: Sundstrom, Michael, et al.
Published: (2006) -
Structural genomics and drug discovery: Case studies on human metabolic enzymes
by: Oppermann, U, et al.
Published: (2007) -
Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions.
by: Oppermann, U, et al.
Published: (2000)